Skip to main content
Fig. 5 | EJNMMI Research

Fig. 5

From: Computational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolization

Fig. 5

Linear regression for dose metrics vs tumor volume. a ∆D50 vs tumor volume (Slopefit = −0.046 Gy/cm3, R 2 = 0.505, P = 0.003). bD avg vs tumor volume (Slopefit = −0.04 Gy/cm3, R 2 = 0.354, P = 0.02). c ∆V100 vs tumor volume (Slopefit = −0.034%/cm3, R 2 = 0.615, P = 5.4e−4)

Back to article page